Abstract
Although conventional proton magnetic resonance imaging has increased our ability to detect brain tumors, it has not enhanced to nearly the same degree our ability to diagnose tumor type1. Proton magnetic resonance spectroscopy is a safe, noninvasive means of performing biochemical analyses in vivo2. Using this technique, we characterized and classified tissue from normal brains, as well as tissue from the five most common types of adult supratentorial brain tumors. These six tissue types differed in their pattern across the six metabolites measured. ‘Leaving–one–out’ linear discriminant analyses based on these resonance profiles correctly classified 104 of 105 spectra, and, whereas conventional preoperative clinical diagnosis misclassified 20 of 91 tumors, the linear discriminant analysis approach missed only 1. Thus, we have found that a pattern–recognition analysis of the biochemical information obtained from proton magnetic resonance spectroscopy can enable accurate, noninvasive diagnosis of the most prevalent types of supratentorial brain tumors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Atlas, S.W. Intraaxial brain tumours, in Magnetic Resonance Imaging of the Brain and Spine (ed. Atlas, S.W.) 223–326 (Raven, New York, 1991).
Arnold, D.L. & Matthews, P.M. Practical aspects of clinical applications of MRS in the brain. in MR Spectroscopy: Clinical Applications and Techniques (eds. Young, I.R. & Charles, H.C.) 139–159 (Martin Dunitz, London, 1996).
Kondziolka, D., Lunsford, L.D. & Martinez, A.J. Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (lowgrade) astrocytoma. J. Neurosurg. 79, 533–536 (1993).
Chandrasoma, P.T. Pathologic evaluation of imaging directed stereotactic biopsy materials. in Malignant Cerebral Glioma (ed. Apuzzo, M.L.J.) 129–140 (American Association of Neurological Surgeons, Park Ridge, Illinois, 1990).
Arnold, D.L., Shoubridge, E.A., Villemure, J.G. & Feindel, W. Proton and phosphorus magnetic resonance spectroscopy of human astrocytomas in vivo. NMR Biomed. 3, 184–189 (1990).
Segebarth, C.M., Baleriaux, D.F. & Luyten, P.R. & den Hollander, J.A. Detection of metabolic heterogeneity of human inracranial tumours in vivo by 1H NMR spectroscopic imaging. NMR Biomed. 13, 62–76 (1990).
Kugel, H. et al. Human brain tumors: Spectral patterns detected with localized H-1 MR spectroscopy. Radiology 183, 701–709 (1992).
Gill, S.S. et al. Proton MR spectroscopy of intracranial tumours: in vivo and in vitro studies. J. Comput. Assist. Tomogr. 14, 497–504 (1990).
Bruhn, H. et al. Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. Radiology 172, 541–548 (1989).
Peeling, J. & Sutherland, G. High-resolution NMR spectroscopy studies of extracts of human cerebral neoplasms. NMR Biomed. 24, 123–136 (1992).
Simmons, M.L., Frondoza, C.G. & Coyle, J.T. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 45, 37–45 (1991).
Brooks, D.J. et al. Studies on the transport of K+, glucose, and albumin across the blood brain barrier in man using positron emission tomography. in Carrier Mediated Transport of Solutes from Blood to Tissue (eds. Yudilevich, D.L. & Mann, G.E.) 195–202 (Longman, New York, 1985).
DiChiro, G. Brain imaging of glucose utilization in cerebral tumors. in Brain Imaging and Brain Function (ed Sokoloff, L.) 185–197 (Raven, NewYork, 1985).
Behar, K.L., Rothman, D.L., Spencer, D.D., Petroff, O.A.C. Analysis of macromolecule resonances in 1H NMR spectra of human brain. Magnet. Reson. Med. 32, 294–302 (1994).
Preul, M.C., Collins, D.L. & Arnold, D.L. Differential diagnosis of human intracranial tumours in vivo using 1H-MR spectroscopic imaging and feature space for spectral pattern recognition. in Magnetic Resonance Scanning and Epilepsy (eds Shorvon, S. D., Fish, D.R., Andermann, F., Bydder, G.M., & Stefan, H.) 299–313 (Plenum, New York, 1993).
Burger, P.C. & Scheithauer, B.W. Atlas of Tumor Pathology: Tumors of the Central Nervous System. (AFIP UAREP, Washington DC, 1994).
Burger, P.C., Scheithauer, B.W. & Vogel, F.S. Surgical Pathology of the Nervous System and its Coverings. 3rd edn. (Churchill Livingstone, New York, 1991).
Lachenbruch, P.A. Discriminant Analysis. (Hafner, New York, 1975).
SYSTAT, Inc. SYSTAT for Windows: Statistics, Version 5 (SYSTAT, Inc., Evanston Illinois, 1992).
Kauppinen, R.A. & Williams, S.R. Nuclear magnetic resonance spectroscopy studies of the brain. Progr. Neurobiol. 44, 87–118 (1994).
Hand, D.J. Discrimination and Classification. (Wiley, Chichester, 1981).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Preul, M., Caramanos, Z., Collins, D. et al. Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy. Nat Med 2, 323–325 (1996). https://doi.org/10.1038/nm0396-323
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm0396-323
This article is cited by
-
Recent advances in understanding brain cancer metabolomics: a review
Medical Oncology (2023)
-
Proton magnetic resonance spectroscopy detects cerebral metabolic derangement in a mouse model of brain coenzyme a deficiency
Journal of Translational Medicine (2022)
-
Metabolic alterations in meningioma reflect the clinical course
BMC Cancer (2021)
-
Prospective multicentre evaluation and refinement of an analysis tool for magnetic resonance spectroscopy of childhood cerebellar tumours
Pediatric Radiology (2018)
-
Improving the utility of 1H-MRS for the differentiation of glioma recurrence from radiation necrosis
Journal of Neuro-Oncology (2017)